Toronto – September 16, 2026 -- Franco-Nevada Corporation has agreed to a A$200 million (approximately $144 million) follow-on financing package with Minerals 260 Limited to advance the Bullabulling Gold Project in Western Australia, lifting its total backing of the project to an aggregate A$420 million (approximately $300 million).

The package comprises a A$170 million (approximately $122 million) gross royalty acquisition and a A$30 million (approximately $22 million) equity subscription as lead order in a future Minerals 260 capital raise.

Melbourne – September 16, 2026 -- IonOpticks has released Aurora Series 5, a nano-LC column platform that sustained over 10,000 unique protein identifications across more than 1,000 injections in extended laboratory testing, without a rise in backpressure beyond 1,400 runs.

Seoul – September 16, 2026 -- A phase III trial of tambotatug pelitecan (Tam-Peli, YL201), an anti-B7-H3 antibody-drug conjugate, cut the risk of death by 54% compared with standard-of-care topotecan in patients with relapsed small-cell lung cancer (SCLC), according to data presented at the IASLC 2026 World Conference on Lung Cancer.

Hong Kong – September 16, 2026 -- Akeso, Inc. (9926.HK) reported that its bispecific antibody ivonescimab reduced the risk of death by 27% compared with Merck's pembrolizumab in a Phase III trial of PD-L1-positive non-small cell lung cancer (NSCLC), with results presented as a Late-Breaking Abstract at the 2026 World Conference on Lung Cancer (WCLC).

Denver – September 16, 2026 -- The International Association for the Study of Lung Cancer (IASLC) has launched a Complimentary IASLC Full Membership program for healthcare professionals in World Bank-designated low-income and lower-middle-income economies, eliminating financial barriers to its global thoracic oncology network.

Beijing – September 16, 2026 -- China's Silk Road Maritime shipping network added 12 new routes at the 8th Silk Road Maritime International Cooperation Forum held in Xiamen from September 8-9, bringing the total to 160 named routes spanning 50 countries and 153 ports worldwide.

Seoul – September 12, 2026 -- SystImmune, Inc. announced that new global Phase 1 data support 2.5 mg/kg D1D8 Q3W as the recommended Phase 3 dose for iza-bren (izalontamab brengitecan), a bispecific EGFRxHER3 antibody drug conjugate, in previously treated EGFR-mutated metastatic non-small cell lung cancer (NSCLC).

Chicago – September 16, 2026 -- Connectbase named eight winners of its 2026 TCWLIVE! Awards, recognizing companies and executives for measurable growth, operational performance and ecosystem impact in the connectivity commerce sector.

Comcast Business Takes Top Connectivity Commerce Leader Award

The awards were presented at The Connected World LIVE! conference, held September 8–11 in Chicago. Comcast Business received the Connectivity Commerce Leader Award, the program's top honor.

Madison, Wis. – September 16, 2026 -- Accuray Incorporated (NASDAQ: ARAY) and RaySearch Laboratories AB (publ) have signed a definitive agreement expanding their collaboration to accelerate adoption of online adaptive radiation therapy, with Accuray committing to purchase RayStation software licenses valued at $8 million.

Beijing – – September 16, 2026 -- The New Development Bank (NDB), the BRICS-backed lender championed by Chinese President Xi Jinping, has approved 139 projects worth roughly $43 billion by the end of 2025, funding renewable energy, transport infrastructure, affordable housing and clean water access across emerging markets.